Semaglutide commonly causes mild nausea, early satiety, or stomach upset during dose escalation
It also supports energy metabolism, red blood cell production, and nervous system function, providing an added benefit alongside the weight loss effects of tirzepatide
TCF7L2 shapes glucose handling and GLP1R and MC4R govern the incretin and satiety signaling a dual agonist engages the individual terrain that decides how tirzepatides two-receptor action plays out
Robust clinical evidence supports the inclusion of agents such as semaglutide and liraglutide for reducing HbA1c levels, achieving substantial weight loss, and mitigating complications associated with T2DM and obesity (16)(39)
But high protein combined with resistance training reduces lean mass loss by 60-80% or more
Tirzepatide also suppresses glucagon secretion, slows gastric emptying, and reduces appetite through central nervous system pathways